Amanta Healthcare Ltd Shows Bullish Momentum Amid Technical Upgrades

Technical Trend Evolution and Price Momentum

Amanta Healthcare’s current price stands at ₹165.05, up 1.57% from the previous close of ₹162.50, with the day’s high touching ₹169.00, which also marks the 52-week high. The stock’s 52-week low is ₹93.10, highlighting a substantial recovery and upward momentum over the past year. The recent price action reflects a strong bullish sentiment, supported by a daily moving average trend that remains firmly positive.

The weekly technical trend has upgraded from mildly bullish to bullish, indicating strengthening momentum over the short to medium term. This is corroborated by the Moving Average Convergence Divergence (MACD) indicator, which is bullish on the weekly timeframe, suggesting that the stock’s upward momentum is gaining traction. However, the monthly MACD remains neutral, implying that while short-term momentum is positive, longer-term confirmation is still developing.

Conversely, the Relative Strength Index (RSI) presents a mixed picture. The weekly RSI is bearish, signalling some short-term overbought conditions or potential consolidation, while the monthly RSI remains neutral. This divergence between MACD and RSI suggests that while momentum is building, investors should be cautious of possible short-term pullbacks or volatility.

Moving Averages and Bollinger Bands Indicate Strength

Daily moving averages are bullish, reinforcing the positive price momentum. The stock price is trading above key moving averages, which often act as dynamic support levels. This alignment typically attracts technical traders and momentum investors, further supporting the bullish case.

Bollinger Bands on the weekly chart are also bullish, with the price approaching the upper band. This indicates increased volatility but also confirms the strength of the current uptrend. The stock’s ability to sustain levels near the upper Bollinger Band will be critical in maintaining momentum.

Volume and Dow Theory Signals

On-Balance Volume (OBV) on the weekly timeframe is mildly bearish, suggesting that volume has not fully confirmed the price gains recently. This divergence between price and volume may warrant caution, as sustained rallies typically require strong volume support. However, the monthly OBV shows no clear trend, indicating a neutral volume backdrop over the longer term.

Dow Theory assessments are bullish on both weekly and monthly charts, providing a strong foundational confirmation of the uptrend. This dual timeframe bullishness supports the view that the stock is in a sustained upward phase, which could attract further institutional interest.

Comparative Returns Highlight Strong Outperformance

Amanta Healthcare’s recent returns have significantly outpaced the broader market benchmark, the Sensex. Over the past week, the stock has gained 2.04%, compared to the Sensex’s 0.86%. The one-month return is particularly impressive at 36.69%, dwarfing the Sensex’s 4.60% gain. Year-to-date, Amanta Healthcare has surged 51.84%, while the Sensex has declined by 8.75%, underscoring the stock’s robust relative strength.

These returns reflect the company’s strong operational performance and positive market sentiment within the pharmaceuticals and biotechnology sector. The stock’s micro-cap status and current Mojo Score of 51.0, upgraded from a previous Sell rating to Hold on 3 July 2026, indicate improving fundamentals and technical outlook. This upgrade signals a cautious but optimistic stance from analysts, recognising the stock’s potential while acknowledging inherent risks associated with smaller capitalisation stocks.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Amanta Healthcare benefits from ongoing industry tailwinds such as increased healthcare spending, innovation in drug development, and rising demand for biotechnology solutions. The sector’s resilience amid broader market volatility has helped support the stock’s bullish technical profile.

While the company remains a micro-cap, its recent technical upgrades and price momentum suggest it is gaining traction among investors seeking growth opportunities in this dynamic sector. The combination of bullish moving averages, MACD, and Dow Theory signals provide a compelling case for continued upside potential, albeit with some caution warranted due to mixed RSI and volume signals.

Outlook and Investor Considerations

Investors analysing Amanta Healthcare should weigh the bullish technical signals against the mixed volume and RSI indicators. The stock’s proximity to its 52-week high of ₹169.00 suggests momentum is strong, but short-term overbought conditions could lead to intermittent profit-taking or consolidation phases.

The upgrade from Sell to Hold by MarketsMOJO on 3 July 2026 reflects a more favourable risk-reward profile, though the Mojo Grade of Hold indicates that investors should maintain a measured approach. The micro-cap nature of the stock implies higher volatility and liquidity considerations compared to larger peers.

Longer-term investors may find the stock’s strong year-to-date return of 51.84% and positive technical trend encouraging, especially given the pharmaceuticals sector’s growth prospects. However, monitoring key technical indicators such as MACD and moving averages for sustained bullish confirmation will be essential to validate the current momentum.

In summary, Amanta Healthcare Ltd’s technical parameter changes reveal a clear shift towards bullish momentum, supported by multiple indicators and strong relative performance versus the Sensex. While some caution is warranted due to volume and RSI signals, the overall technical landscape favours a positive outlook for the stock in the near to medium term.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today